| mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.003 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.004 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.005 |
| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.006 |
| mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
0.006 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.009 |
| mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
-0.34 |
0.01 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |